Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Cipher Pharmaceuticals, Inc. (DND) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cipher Pharmaceuticals is a growing specialty pharmaceutical company that commercializes novel formulations of successful, currently marketed molecules. The company has three products: Lipofen®, a fenofibrate formulation marketed in the U.S.; an extended-release tramadol marketed as ConZip™ in the U.S. and … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Fluoropharma, Inc. (FPMI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Fluoropharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FPMI’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Cell Therapeutics, Inc. (CTIC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cell Therapeutics is engaged in the development, acquisition and commercialization of drugs for the treatment of cancer. The company is developing Pixuvri for the treatment of hematologic malignancies and solid tumors; OPAXIO for treating ovarian, brain, esophageal, head and neck … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Integrated Silicon Solution, Inc. (ISSI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Integrated Silicon Solution designs, develops and markets high-performance integrated circuits for the automotive, communications, digital consumer, and industrial/medical/military markets. The company’s primary products are high-speed and low power SRAM, and low and medium density DRAM. ISSI also designs and markets … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Cynosure, Inc. (CYNO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cynosure develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

SpectraScience, Inc. (SCIE) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

SpectraScience is a medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The company’s WavSTAT Optical Biopsy System uses light … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

VIVUS, Inc. (VVUS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for U.S., European and other world markets. The company has two late-stage clinical development programs in progress that target … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Longhai Steel, Inc. (LGHS) Differentiates Itself through Superior Manufacturing and Distribution

Longhai, through its Chinese operating company, produces various sizes of high quality steel wire products in two wire production plants, with a total annual capacity of approximately 1.5 million metric tons. The company’s output is sold to several distributors who … Continue reading

Posted in Longhai Steel Inc. LGHS | Leave a comment

InVivo Therapeutics Holdings Corp. (NVIV) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

InVivo Therapeutics Holdings is a medical device company focused on the development and commercialization of groundbreaking technologies for the treatment of spinal cord injuries (SCI). NVIV’s technologies encompass multiple strategies involving biomaterials, FDA-approved drugs, growth factors and human neural stem … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Elephant Talk Communications Corp. (ETAK) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Elephant Talk Communications provides mobile networking software and services. The company’s products include remote health care, credit card fraud prevention, mobile internet ID security, multi-country phone services, loyalty management services and a range of other emerging mobile services. Through its … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment